Detalles de la búsqueda
1.
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.
Ophthalmology
; 2024 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280653
2.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Ophthalmology
; 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382813
3.
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.
Graefes Arch Clin Exp Ophthalmol
; 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38847896
4.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Lancet
; 399(10326): 741-755, 2022 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085503
5.
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
Ophthalmology
; 130(7): 735-747, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36870451
6.
Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Ophthalmology
; 125(6): 842-849, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29366564
7.
Treatment Patterns for Myopic Choroidal Neovascularization in the United States: Analysis of the IRIS Registry.
Ophthalmology
; 124(7): 935-943, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28372860
8.
The Prevalence of Myopic Choroidal Neovascularization in the United States: Analysis of the IRIS(®) Data Registry and NHANES.
Ophthalmology
; 123(8): 1771-1782, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27342789
9.
Treatment Patterns for Diabetic Macular Edema: An Intelligent Research in Sight (IRIS®) Registry Analysis.
Ophthalmology
; 127(3): 427-429, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31767437
10.
Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema.
Invest Ophthalmol Vis Sci
; 65(5): 26, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758639
11.
Physical Activity in Functionally Monocular Persons in the United States, 2003-2006.
Transl Vis Sci Technol
; 12(2): 13, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36757341
12.
Population Pharmacokinetics of Ranibizumab Delivered via the Port Delivery System Implanted in the Eye in Patients with Neovascular Age-Related Macular Degeneration.
J Clin Pharmacol
; 63(11): 1210-1220, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37291950
13.
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale.
Ophthalmol Sci
; 3(3): 100302, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37810589
14.
Visual field loss and accelerometer-measured physical activity in the United States.
Ophthalmology
; 119(12): 2486-92, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22892152
15.
Impact of community-based behaviour-change management on perceived neonatal morbidity: a cluster-randomized controlled trial in Shivgarh, Uttar Pradesh, India.
J Trop Pediatr
; 58(4): 286-91, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22147281
16.
Management of Key Ocular Adverse Events in Patients Implanted with the Port Delivery System with Ranibizumab.
Ophthalmol Retina
; 6(11): 1028-1043, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35589078
17.
YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale.
Ophthalmol Sci
; 2(1): 100111, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36246184
18.
Utilization and perceptions of neonatal healthcare providers in rural Uttar Pradesh, India.
Int J Qual Health Care
; 23(4): 487-94, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21669971
19.
Feasibility Study of a Multimodal, Cloud-Based, Diabetic Retinal Screening Program in a Workplace Environment.
Transl Vis Sci Technol
; 10(6): 20, 2021 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34111266
20.
TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration.
Ophthalmol Sci
; 1(4): 100076, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36246941